Lymphedema Tailwinds And AI Workflow Efficiencies Will Drive Significant Long Term Upside

AnalystHighTarget

Analyst High Target compiles bullish analysts opinions to create narratives which represent one standard deviation above the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls

Published

12 Dec 25

Updated

23 Jul 26

Views

Not Invested

Shared on 23 Jul 26

Fair value Increased 31%

TCMD: Margin Expansion And New Therapies Will Support Future Upside

Tactile Systems Technology rolls out a new version of its respiratory therapy vest and adds a new leg-compression option for U.S. military and veterans through an exclusive deal. Analysts also become more optimistic as the company points to improving profitability and gives a stronger outlook for the year.

0 views

Fair Value vs Share Price

US$42

vs US$24.1542.5% undervalued

9.8%

Revenue growth

12.6%

Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Tactile Systems Technology

Fair value estimate changes
Narrative and analyst updates
Key company announcements

Company analysis

Flawless balance sheet and undervalued.

Market capUS$657.3m

PB2.4x

Estimated Growth8.3%

Dividend YieldN/A

Full analysis

CEO & management

Sheri Dodd

CEO

2.7yrs

CEO Tenure

A medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.